IE781550L - Bis-(tetrahydroisoquinolinium) salt; neuromuscular blocking¹agent - Google Patents
Bis-(tetrahydroisoquinolinium) salt; neuromuscular blocking¹agentInfo
- Publication number
- IE781550L IE781550L IE781550A IE155078A IE781550L IE 781550 L IE781550 L IE 781550L IE 781550 A IE781550 A IE 781550A IE 155078 A IE155078 A IE 155078A IE 781550 L IE781550 L IE 781550L
- Authority
- IE
- Ireland
- Prior art keywords
- carbon atoms
- image
- pharmaceutically acceptable
- tetrahydroisoquinolinium
- neuromuscular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Short acting reversible neuromuscular blocking agents of the formula: <IMAGE> where B and C are para or preferably meta, and each is <IMAGE> where m is 2, 3 or 4 and is preferably 2, R1, R2, R3, R4, R5, R6 and R7 are the same or different and are hydrogen or alkoxy of 1 to 4 carbon atoms, Y is alkyl of 1 to 4 carbon atoms, n is 2, 3 or 4, most preferably 3, provided that at least one of R1 to R4 and one of R5 to R7 is lower alkoxy, and X is a pharmaceutically acceptable anion are useful upon administration to a patient in providing muscular relaxation in the patient during surgery and are normally intravenously administered in a pharmaceutically acceptable carrier.
[GB2002758A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82079477A | 1977-08-01 | 1977-08-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE781550L true IE781550L (en) | 1979-02-01 |
IE47014B1 IE47014B1 (en) | 1983-11-30 |
Family
ID=25231743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1550/78A IE47014B1 (en) | 1977-08-01 | 1978-07-31 | Neuromuscular blocking agents |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS5455577A (en) |
AT (1) | AT368496B (en) |
AU (1) | AU523706B2 (en) |
BE (1) | BE869415A (en) |
CA (1) | CA1113096A (en) |
DD (1) | DD143254A5 (en) |
DE (1) | DE2833505A1 (en) |
DK (1) | DK339078A (en) |
ES (1) | ES472229A1 (en) |
FI (1) | FI782363A (en) |
FR (1) | FR2399429A1 (en) |
GB (1) | GB2002758B (en) |
IE (1) | IE47014B1 (en) |
IL (1) | IL55254A (en) |
LU (1) | LU80062A1 (en) |
MC (1) | MC1197A1 (en) |
NL (1) | NL7808067A (en) |
PL (1) | PL121492B1 (en) |
SE (1) | SE7808267L (en) |
SU (1) | SU862820A3 (en) |
ZA (1) | ZA784331B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1125287A (en) * | 1978-07-21 | 1982-06-08 | John J. Savarese | Bis isoquinolinium compositions and methods of use |
US4235906A (en) | 1978-07-21 | 1980-11-25 | Massachusetts General Hospital | Bis-isoquinolinium compounds, compositions and methods of use |
JPS5645459A (en) * | 1979-09-20 | 1981-04-25 | Otsuka Pharmaceut Co Ltd | Cyclic amine |
JPS5899465A (en) * | 1981-11-23 | 1983-06-13 | ザ・ウエルカム・フアウンデ−シヨン・リミテツド | Isoquinoline derivative |
GB8418303D0 (en) * | 1984-07-18 | 1984-08-22 | Wellcome Found | Compounds |
JPH0555438A (en) * | 1991-08-26 | 1993-03-05 | Rohm Co Ltd | Lead terminal structure of electronic component |
AU745382B2 (en) * | 1997-03-25 | 2002-03-21 | Cornell Research Foundation Inc. | Substituted isoquinolines as ultra short acting neuromuscular blockers |
ATE554769T1 (en) * | 2006-12-06 | 2012-05-15 | Cornell Res Foundation Inc | MEDIUM-DURING NEUROMUSCULAR BLOCKERS AND ANTAGONISTS ADVON |
US8592451B2 (en) | 2009-03-17 | 2013-11-26 | Cornell University | Reversible nondepolarizing neuromuscular blockade agents and methods for their use |
WO2011022491A1 (en) | 2009-08-19 | 2011-02-24 | Cornell University | Cysteine for physiological injection |
CN114057642B (en) * | 2021-12-10 | 2023-03-28 | 广东嘉博制药有限公司 | Synthetic method of mickey ammonium chloride intermediate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5156762U (en) * | 1974-10-28 | 1976-05-04 |
-
1978
- 1978-07-31 BE BE189624A patent/BE869415A/en not_active IP Right Cessation
- 1978-07-31 ES ES472229A patent/ES472229A1/en not_active Expired
- 1978-07-31 CA CA308,434A patent/CA1113096A/en not_active Expired
- 1978-07-31 AU AU38476/78A patent/AU523706B2/en not_active Expired
- 1978-07-31 NL NL787808067A patent/NL7808067A/en not_active Application Discontinuation
- 1978-07-31 SE SE7808267A patent/SE7808267L/en unknown
- 1978-07-31 LU LU80062A patent/LU80062A1/en unknown
- 1978-07-31 JP JP9353778A patent/JPS5455577A/en active Pending
- 1978-07-31 DD DD78207041A patent/DD143254A5/en unknown
- 1978-07-31 GB GB7831697A patent/GB2002758B/en not_active Expired
- 1978-07-31 IE IE1550/78A patent/IE47014B1/en unknown
- 1978-07-31 IL IL55254A patent/IL55254A/en unknown
- 1978-07-31 ZA ZA00784331A patent/ZA784331B/en unknown
- 1978-07-31 FI FI782363A patent/FI782363A/en not_active Application Discontinuation
- 1978-07-31 MC MC781316A patent/MC1197A1/en unknown
- 1978-07-31 SU SU782646252A patent/SU862820A3/en active
- 1978-07-31 DK DK339078A patent/DK339078A/en not_active Application Discontinuation
- 1978-07-31 AT AT0555478A patent/AT368496B/en not_active IP Right Cessation
- 1978-07-31 DE DE19782833505 patent/DE2833505A1/en not_active Withdrawn
- 1978-07-31 FR FR7822577A patent/FR2399429A1/en active Granted
- 1978-07-31 PL PL1978208757A patent/PL121492B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
LU80062A1 (en) | 1979-05-15 |
FI782363A (en) | 1979-02-02 |
DK339078A (en) | 1979-02-02 |
BE869415A (en) | 1979-01-31 |
PL208757A1 (en) | 1979-06-04 |
PL121492B1 (en) | 1982-05-31 |
ATA555478A (en) | 1982-02-15 |
IE47014B1 (en) | 1983-11-30 |
AU3847678A (en) | 1980-02-07 |
JPS5455577A (en) | 1979-05-02 |
AU523706B2 (en) | 1982-08-12 |
DE2833505A1 (en) | 1979-04-05 |
NL7808067A (en) | 1979-02-05 |
ES472229A1 (en) | 1979-03-16 |
CA1113096A (en) | 1981-11-24 |
ZA784331B (en) | 1979-12-27 |
MC1197A1 (en) | 1979-03-19 |
SU862820A3 (en) | 1981-09-07 |
IL55254A (en) | 1983-03-31 |
SE7808267L (en) | 1979-02-02 |
IL55254A0 (en) | 1978-09-29 |
FR2399429B1 (en) | 1981-07-17 |
GB2002758B (en) | 1982-02-03 |
AT368496B (en) | 1982-10-11 |
DD143254A5 (en) | 1980-08-13 |
FR2399429A1 (en) | 1979-03-02 |
GB2002758A (en) | 1979-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920002144A (en) | Inflammatory bowel disease prevention and treatment containing zinc L-carnosine salt or its complex as an active ingredient | |
IE44246L (en) | Heterocyclyloxypropanolamines | |
IE781550L (en) | Bis-(tetrahydroisoquinolinium) salt; neuromuscular blocking¹agent | |
ATE60759T1 (en) | BISDIMETHOXYMETHYL(TRIMETHOXYBENZYL)ISOCHINOLINIUM SALTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
KR900701282A (en) | Treatment, prevention of ischemic diseases of the heart or brain | |
ES468173A1 (en) | 14-Amino derivatives of morphine, methods of making them and analgesic compositions containing them | |
KR910007867A (en) | Phenotanolamine Compound | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
GB9108629D0 (en) | Heterocyclic pharmaceutical compounds,preparation and use | |
ES468170A1 (en) | 14-Amino derivatives of morphine, methods of making them and analgesic compositions containing them | |
JO1629B1 (en) | Indenoindoles i | |
ES475533A1 (en) | Novel propione amide derivative and its manufacture | |
UA41329C2 (en) | pharmaceutical composition for the treatment of disorders of cardiac rhythm by large mammals and humans, derivatives of 3,7,9,9-tetrazubstituted 3,7-diazabicyclo[3,3,1]nonan and a medicament for the treatment of arrhythmia | |
IE781897L (en) | PYRIMIDO £2,1-a| ISOQUINOLINE -4-ONES | |
IE790108L (en) | Isoquinoline compounds | |
GB2129425B (en) | 5-halovinyl-2'-deoxyuridine derivatives | |
GB1519210A (en) | Antiarrythmic compositions containing pyrrolidinyl derivatives | |
GB1364284A (en) | Acylaminophyrrolidinone derivatives their preparation and pharma ceutical compositions containing them | |
ES376688A1 (en) | Benzdiazepine derivatives | |
JPS6440425A (en) | Therapeutical composition for cardiac arrhythmia | |
GB1531781A (en) | N-propargyl-piperonylamine and its preparation and use | |
WO1996000726A3 (en) | New brefeldin a derivatives and their utility in the treatment of cancer | |
KR880001630A (en) | 5-fluorouracil derivatives and uses thereof | |
ES8308332A1 (en) | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same. | |
ES476124A1 (en) | Amino acid derivatives, process for obtaining them, intermediate compounds in obtaining them and pharmaceutical compositions containing them. |